| |
 |
|
Class Information
Number: 424/234.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.)
Description: Subject matter involving a bacterium, a component of a bacterium, or a substance produced by a bacterium.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/246.1 |
Bacillus |
67 |
| 424/253.1 |
Bordetella (e.g., bordetella bronchiseptica, etc.) |
68 |
| 424/252.1 |
Brucella (e.g., brucella abortus, brucella canis, etc.) |
30 |
| 424/263.1 |
Chlamydia (e.g., chlamydia trachomatis, etc.) |
77 |
| 424/247.1 |
Clostridium (e.g., clostridium tetani, clostridium difficile, clostridium perfringens, clostridium botulinum, clostridium chauvoei, etc.) |
92 |
| 424/245.1 |
Corynebacterium (e.g., corynebacterium diphtheriae, etc.) |
47 |
| 424/257.1 |
Escherichia (e.g., escherichia coli, etc.) |
147 |
| 424/256.1 |
Hemophilus (e.g., hemophilus influenzae, hemophilus gallinarum, hemophilus pleuropnemoniae, etc.) |
196 |
| 424/259.1 |
Klebsiella (e.g., klebsiella pneumoniae, etc.) |
30 |
| 424/251.1 |
Moraxella (e.g., moraxella bovis, etc.) |
55 |
| 424/248.1 |
Mycobacterium (e.g., mycobacterium tuberculosis, calmette-guerin bacillus (i.e., bcg), etc.) |
228 |
| 424/264.1 |
Mycoplasma |
45 |
| 424/249.1 |
Neisseria (e.g., neisseria gonorrhoeae, etc.) |
91 |
| 424/255.1 |
Pasteurella (e.g., pasteurella multocida, pasteurella hemolytica, etc.) |
88 |
| 424/242.1 |
Pilus, fimbria, or adhesin |
81 |
| 424/260.1 |
Pseudomonas (e.g., pseudomonas aeruginosa, etc.) |
89 |
| 424/258.1 |
Salmonella (e.g., salmonella typhimurium, etc.) |
142 |
| 424/243.1 |
Staphylococcus (e.g., staphylococcus aureus, etc.) |
106 |
| 424/244.1 |
Streptococcus (e.g., group b streptococcus, pneumococcus or streptococcus pneumoniae, etc.) |
295 |
| 424/236.1 |
Toxin or toxoid, except endotoxin (e.g., exotoxin, enterotoxin, etc.) |
321 |
| 424/235.1 |
Transposon mutant or deletion mutant bacterium (e.g., produced by transposon mutagenesis, etc.) |
93 |
| 424/262.1 |
Treponema (e.g., treponema hyodysenteriae, treponema pallidum, etc.) |
42 |
| 424/261.1 |
Vibrio (e.g., vibrio cholera, etc.) |
81 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7371821 |
Cloning and expression of the full length 110 kDa antigen of Orientia tsutsugamushi to be used as a vaccine component against scrub typhus |
May. 13, 2008 |
| 7371394 |
Antigenic composition of a Pseudomonas aeruginosa protein |
May. 13, 2008 |
| 7371393 |
Methods for reducing fecal shedding |
May. 13, 2008 |
| 7368261 |
Conserved Neisserial antigens |
May. 6, 2008 |
| 7364740 |
Molecular differences between species of the M. tuberculosis complex |
Apr. 29, 2008 |
| 7361348 |
Immunogenic glycopeptides, screening, preparation and uses |
Apr. 22, 2008 |
| 7358062 |
Method for diagnosing atrophic gastritis |
Apr. 15, 2008 |
| 7357932 |
Surface protein of Neisseria bacteria |
Apr. 15, 2008 |
| 7351550 |
Exoenzyme toxin of Aeromonas salmonicida, and uses thereof |
Apr. 1, 2008 |
| 7344724 |
UspA1 and UspA2 antigens of Moraxella catarrhalis |
Mar. 18, 2008 |
| 7344719 |
Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof |
Mar. 18, 2008 |
| 7344703 |
Mycobacterial sulfation pathway proteins and methods of use thereof |
Mar. 18, 2008 |
| 7341732 |
Methods for treating mastitis in a milk producing animal |
Mar. 11, 2008 |
| 7338786 |
Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
Mar. 4, 2008 |
| 7335493 |
Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
Feb. 26, 2008 |
| 7335480 |
Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same |
Feb. 26, 2008 |
| 7335370 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
Feb. 26, 2008 |
| 7335368 |
BVH-A2 and BVH-A3 antigens of group B Streptococcus |
Feb. 26, 2008 |
| 7332173 |
Group A streptococcal polysaccharide immunogenic compositions and methods |
Feb. 19, 2008 |
| 7332171 |
Ehrlichia chaffeensis 28 kDa outer membrane protein multigene family |
Feb. 19, 2008 |
| 7329738 |
Assays for detection of Bacillus anthracis |
Feb. 12, 2008 |
| 7329409 |
Compositions and methods for treatment of microbial infections |
Feb. 12, 2008 |
| 7326770 |
H. pylori fucosyltransferases |
Feb. 5, 2008 |
| 7326545 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
Feb. 5, 2008 |
| 7326544 |
Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
Feb. 5, 2008 |
| 7326419 |
Surface protein of Leptospira |
Feb. 5, 2008 |
| 7323180 |
Use of cross-protection to identify novel vaccine candidates for infectious agents |
Jan. 29, 2008 |
| 7323179 |
Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections |
Jan. 29, 2008 |
| 7323175 |
Immunogenicity of glucan binding protein |
Jan. 29, 2008 |
| 7320794 |
Transporter protein |
Jan. 22, 2008 |
| 7312065 |
Lawsonia intracellularis of European origin and vaccines, diagnostic agents and methods of use thereof |
Dec. 25, 2007 |
| 7311917 |
Moraxella catarrhalis protein, gene sequence and uses thereof |
Dec. 25, 2007 |
| 7306808 |
Orientia tsutsugamushi truncated recombinant outer membrane protein (r47) and (r57) vaccines diagnostics and therapeutics for scrub typhus |
Dec. 11, 2007 |
| 7304139 |
Polynucleotides and polypeptides of Anaplasma phagocytophilum and methods of using the same |
Dec. 4, 2007 |
| 7300660 |
Abundant extracellular products and methods for their production and use |
Nov. 27, 2007 |
| 7300659 |
Enterohemorrhagic Escherichia coli vaccine |
Nov. 27, 2007 |
| 7297339 |
Rhodococcus equi mutants and vaccines comprising same |
Nov. 20, 2007 |
| 7297338 |
Avian vaccine composition for the protection of poultry against disease and infection caused by E. coli and Salmonella |
Nov. 20, 2007 |
| 7291343 |
Enterococcus antigens and vaccines |
Nov. 6, 2007 |
| 7291325 |
Method for producing target proteins by deleting or amplifying ibpA and/or ibpB gene coding for inclusion body-associated proteins |
Nov. 6, 2007 |
| 7288261 |
Mid-life vaccine and methods for boosting anti-mycobacterial immunity |
Oct. 30, 2007 |
| 7285289 |
Nanoparticle vaccines |
Oct. 23, 2007 |
| 7285276 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
Oct. 23, 2007 |
| 7279170 |
32-kDa protein derived from Mycobacterium tuberculosis and related peptides |
Oct. 9, 2007 |
| 7279169 |
Mucosal DTPa vaccines |
Oct. 9, 2007 |
| 7279168 |
Recombinant virus expressing foreign DNA encoding feline CD86 and uses thereof |
Oct. 9, 2007 |
| 7276350 |
Method for diagnosing infectious diseases |
Oct. 2, 2007 |
| 7273722 |
Neurotoxins with enhanced target specificity |
Sep. 25, 2007 |
| 7273611 |
Proteinase K resistant surface protein of neisseria meningitidis |
Sep. 25, 2007 |
| 7273602 |
Immunotherapy for humans |
Sep. 25, 2007 |
|
|
|
